Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Telmisartan MeSH Descriptor Data 2025


MeSH Heading
Telmisartan
Tree Number(s)
D02.455.426.559.389.185.849
D03.633.100.103.791
Unique ID
D000077333
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077333
Scope Note
A biphenyl compound and benzimidazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION.
Entry Term(s)
4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid
BIBR 277
BIBR-277
Micardis
Pritor
Pharm Action
Antihypertensive Agents
Angiotensin II Type 1 Receptor Blockers
Registry Numbers
U5SYW473RQ
0
CAS Type 1 Name
(1,1'-Biphenyl)-2-carboxylic acid, 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-
Public MeSH Note
2019; TELMISARTAN was indexed under BENZIMIDAZOLES and BENZOATES 1993-2018
History Note
2019 (1993)
Date Established
2019/01/01
Date of Entry
2018/07/09
Revision Date
2018/02/27
Telmisartan Preferred
BIBR 277 Narrower
Pritor Narrower
Micardis Narrower
page delivered in 0.15s